ResultsIQ

ResultsIQ › Latest results › Oriental Aromatics Limited

Oriental Aromatics Limited Q1 FY27 results deck summary

NSE: OAL · BSE: 500078

Results deck of 31 Jul 2026, summarised by AI from the filing.

Q1-FY27 revenue ₹2,598 mn, EBITDA margin 7.62% and PAT ₹25 mn; net debt-to-equity improved to 0.56x.

Key takeaways

  1. Q1 revenue Revenue from operations ₹2,598 mn (Q1-FY26: ₹2,255 mn, +15.2%; Q4-FY26: ₹2,824 mn, -8.0%).
  2. EBITDA margin EBITDA margin 7.62% (Q1-FY26: 8.03%, -41 bps; Q4-FY26: 6.91%, +71 bps).
  3. Volumes Sales volumes rose 22% YoY and production volumes 18% YoY on sustained demand and healthy capacity utilisation.
  4. Raw material EBITDA margin was lower YoY by 41 basis points, primarily due to elevated raw material costs.

Original filing on BSE

Oriental Aromatics Limited Q1 FY27 results

As filed: Revenue ₹260 cr (+15% year on year), EBITDA ₹19.8 cr (+4% year on year), PAT ₹2.5 cr (+151% year on year), EBITDA margin 7.6% (−79 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹282 cr (+12% year on year), EBITDA ₹19.5 cr (−3% year on year), PAT ₹4.0 cr (+299% year on year), EBITDA margin 6.9% (−101 bps). Score 41 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit growth was well above it. EBITDA margin fell 101 bps year on year. Other income 58% of PBT. Tax rate 46%. Share price after the results: +11.6% in 30 days (Nifty 500: +2.5%).
  • Q3 FY26: Revenue ₹252 cr (+13% year on year), EBITDA ₹13.2 cr (−40% year on year), PAT −₹1.9 cr (−127% year on year), EBITDA margin 5.3% (−461 bps). Score 20 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 461 bps year on year. Revenue fell 7% from last quarter. Share price after the results: −23.9% in 29 days (Nifty 500: −9.6%).
  • Q2 FY26: Revenue ₹271 cr (+14% year on year), EBITDA ₹18.0 cr (−36% year on year), PAT ₹1.0 cr (−93% year on year), EBITDA margin 6.6% (−517 bps). Score 28 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin fell 517 bps year on year. Other income 100% of PBT. Tax rate 67%. Share price after the results: −14.8% in 30 days (Nifty 500: −0.8%).
  • Q1 FY26: Revenue ₹226 cr (+5% year on year), EBITDA ₹19.0 cr (−14% year on year), PAT ₹1.0 cr (−91% year on year), EBITDA margin 8.4% (−178 bps). Score 23 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 178 bps year on year. Tax rate 67%. Revenue fell 11% from last quarter. Share price after the results: −3.5% in 28 days (Nifty 500: +1.7%).
  • Q4 FY25: Revenue ₹253 cr (+17% year on year), EBITDA ₹20.0 cr (0% year on year), PAT ₹1.0 cr (−90% year on year), EBITDA margin 7.9% (−135 bps). Score 38 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 135 bps year on year. Tax rate 50%. Profit fell 86% from last quarter. Share price after the results: −8.9% in 30 days (Nifty 500: +3.1%).
  • Q3 FY25: Revenue ₹223 cr (+13% year on year), EBITDA ₹22.0 cr (+57% year on year), PAT ₹7.0 cr (+133% year on year), EBITDA margin 9.9% (+276 bps). Score 54 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it. EBITDA margin rose 276 bps year on year. Revenue fell 6% from last quarter.
  • Q2 FY25: Revenue ₹237 cr (+4% year on year), EBITDA ₹28.0 cr (+180% year on year), PAT ₹15.0 cr (+300% year on year), EBITDA margin 11.8% (+741 bps). Score 78 of 100, Above trend. EBITDA margin rose 741 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Oriental Aromatics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.